Literature DB >> 22341573

Synthesis, biological evaluation and molecular investigation of fluorinated peroxisome proliferator-activated receptors α/γ dual agonists.

Giuseppe Fracchiolla1, Antonio Laghezza, Luca Piemontese, Mariagiovanna Parente, Antonio Lavecchia, Giorgio Pochetti, Roberta Montanari, Carmen Di Giovanni, Giuseppe Carbonara, Paolo Tortorella, Ettore Novellino, Fulvio Loiodice.   

Abstract

PPARs are transcription factors that govern lipid and glucose homeostasis and play a central role in cardiovascular disease, obesity, and diabetes. Thus, there is significant interest in developing new agonists for these receptors. Given that the introduction of fluorine generally has a profound effect on the physical and/or biological properties of the target molecule, we synthesized a series of fluorinated analogs of the previously reported compound 2, some of which turned out to be remarkable PPARα and PPARγ dual agonists. Docking experiments were also carried out to gain insight into the interactions of the most active derivatives with both receptors. Copyright Â
© 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22341573     DOI: 10.1016/j.bmc.2012.01.025

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  6 in total

1.  Structural basis for PPAR partial or full activation revealed by a novel ligand binding mode.

Authors:  Davide Capelli; Carmen Cerchia; Roberta Montanari; Fulvio Loiodice; Paolo Tortorella; Antonio Laghezza; Laura Cervoni; Giorgio Pochetti; Antonio Lavecchia
Journal:  Sci Rep       Date:  2016-10-06       Impact factor: 4.379

2.  New approaches for prevention and treatment of Alzheimer's disease: a fascinating challenge.

Authors:  Luca Piemontese
Journal:  Neural Regen Res       Date:  2017-03       Impact factor: 5.135

3.  Natural Scaffolds with Multi-Target Activity for the Potential Treatment of Alzheimer's Disease.

Authors:  Luca Piemontese; Gabriele Vitucci; Marco Catto; Antonio Laghezza; Filippo Maria Perna; Mariagrazia Rullo; Fulvio Loiodice; Vito Capriati; Michele Solfrizzo
Journal:  Molecules       Date:  2018-08-29       Impact factor: 4.411

4.  Chiral phenoxyacetic acid analogues inhibit colon cancer cell proliferation acting as PPARγ partial agonists.

Authors:  Lina Sabatino; Pamela Ziccardi; Carmen Cerchia; Livio Muccillo; Luca Piemontese; Fulvio Loiodice; Vittorio Colantuoni; Angelo Lupo; Antonio Lavecchia
Journal:  Sci Rep       Date:  2019-04-01       Impact factor: 4.379

Review 5.  Heterocyclic compounds as key structures for the interaction with old and new targets in Alzheimer's disease therapy.

Authors:  Asha Hiremathad; Luca Piemontese
Journal:  Neural Regen Res       Date:  2017-08       Impact factor: 5.135

6.  Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors.

Authors:  Leonardo Brunetti; Antonio Carrieri; Luca Piemontese; Paolo Tortorella; Fulvio Loiodice; Antonio Laghezza
Journal:  Int J Mol Sci       Date:  2020-09-24       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.